We retrospectively analyzed the patients who received azacitidine in our center in the course of treatment of their post-transplant relapse. We identified 31 patients. Relapse occurred at a median ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, dosage and administration, and safety of azacitidine are reviewed. Summary: Azacitidine is the first drug in a new class of ...

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...

Azacitidine is an antineoplastic agent, prescribed for blood cancer. The risk or severity of adverse effects can be increased when Azacitidine is combined with Bacillus calmette-guerin substrain ...

The phase III SELECT-MDS-1 study evaluated tamibarotene in combination with azacitidine, a chemotherapy, in newly diagnosed HR-MDS patients with RARα gene overexpression. Per the data readout ...

The medicines and health conditions are: venetoclax (brand name Venclexta) in combination with azacitidine or cytarabine for a type of blood cancer called acute myeloid leukaemia azacitidine to be ...

Citing Phase 1 data the company announced, Citi analyst Yigal Nochomovitz noted that SL-172154 with chemotherapy azacitidine ...